Keith Loria

Cannabis may accentuate the effects of HIV on the brain or perhaps may mitigate them because of its anti-inflammatory properties.

Ribó is the faculty advisor to new POCN Center for HIV Excellence that will provide information and resources to providers who may see relatively few patients with HIV.

‘Yes, PrEP is very important and very useful, but its use is complemented extremely by HIV treatment, so you really have to do both,’ says researcher.

Medicare Advantage plans have been associated with increased screening rates. But managed care tactics and narrow networks may be a disadvantage for people needing care.

A team of researchers studied 22 HIV 'post-treatment controllers' — people whose HIV infections are kept in check even after stopping antiretroviral therapy.

A Kaiser Permanente study shows a close link between HIV RNA levels and low CD4 counts and the risk of heart failure.

Stem cell transplants are not being proposed as treatments for HIV, but this case and a handful of others offer promising confirmation that HIV is not entirely incurable.

The known benefits of antiretroviral therapy (ART) in pregnant persons living with HIV outweigh the risks, which include low-birth weight and metabolic complications for the pregnant person, says the lead author of a review article ART and adverse outcomes published in the New England Journal of Medicine.

Researchers report positive result from a phase 1 trial that show the presence of the antiviral medication in rectal tissue.

Uptake of pre-exposure prophylaxis (PrEP) has been slow. A survey shows that safety and side effects are the top concerns.

Gastroesophageal reflux disease is a risk factor for what is now the more common type of esophageal cancer, adenocarcinoma. Immunotherapy is coming on strong as a treatment.

Tulane University researchers are studying whether dysregulation of the oral microbiome might affect HIV outcomes. They are using rhesus monkeys and SIV infection as a model.

The researchers have several suggestions for how harm from screening should be reported in screening guidelines.

Results of research by Swiss investigators show effector memory T cells bounce back quickly after autologous hematopoietic stem cell transplantation.

Florida has among the largest populations of people living with HIV in the country. We spoke with a clinician with 40 years of experience taking care of Floridians with HIV.

Research results published in Cell Reports implicate the Nef protein as a possible cause of disease-causing inflammation that persists even when an HIV infection is controlled.

HIV hides out and replicates in the spleen, the lymph nodes and other reservoirs. Emmanuel Okala hopes to develop nanotechnology that will flush it out.

University of Arkansas researchers added to the understanding of how anxiety affects sleep with research that looked for associations between anxiety and bedtime procrastination and other patterns of poor sleep.

Dana-Farber Cancer Institute tool evaluates the probability of having genetic mutations that confer elevated risk for 18 cancers.

Results of a small study published in Nature Medicine show that early treatment with a monoclonal antibody might be part of a strategy to clear an HIV infection.

Gilead Sciences reported results from several studies of its antiretroviral.

In a conversation with Managed Healthcare Executive®, Genoa Healthcare Sales Director Jennifer Finocchiaro discusses social determinants of health, the LGBTQ+ community and the demographic contours of the HIV/AIDS epidemic.

Researchers at Harvard-affiliated Brigham and Women's Hospital identified common beliefs among parents and caregivers and also evidence showing they were wrong. They say that they hope this kind of research will lead to public outreach and education efforts to turn people away from misinformation.

Small study finds that sleep deprivation increases white blood cells. The finding is a piece of a puzzle that may link poor sleep to inflammation and a number of diseases.

Escalating costs are hitting patients hard. CMS price negotiation and the $2,000 cap on Part D out-of-pocket expenses should benefit many patients with Medicare coverage.

Escalating costs are hitting patients hard. CMS price negotiation and the $2,000 cap on Part D out-of-pocket expenses should benefit many patients with Medicare coverage.

About 40% of people monkeypox also had HIV, according to a CDC study that included almost 2,000 monkeypox cases in the U.S. that occurred during the first two months of the outbreak.